CHGCY Chugai Pharmaceutical Co., Ltd.

OTC
$22.46

Chugai Pharmaceutical Co., Ltd. (CHGCY) is expected to report earnings on January 26, 2027, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of +10.3% since its last earnings release on October 27, 2026.

Chugai Pharmaceutical Co., Reported Earnings
Tuesday, October 27, 2026 · 12:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 26
Tuesday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $22.14

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Chugai Pharmaceutical Co., Ltd.

CHUGAI PHARMACEUTICAL CO. LTD. is mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products for treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. CHUGAI PHARMACEUTICAL CO. LTD. is based in Tokyo, Japan.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.